Healthcare · Diagnostics Research · NYSE
| Market cap | $12.79B |
|---|---|
| Trailing P/E | 21.4 |
| FCF yield | 3.8% |
| Revenue growth (YoY) | +3.7% |
| EPS growth (YoY) | +3.5% |
| FCF/share growth (YoY) | -0.9% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Revvity, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Buy | $15,001 | Jun 5, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | May 7, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Aug 13, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Aug 13, 2025 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Jul 8, 2025 |
| April McClain Delaney | House | Sell | $15,001 - $50,000 | Mar 1, 2025 |
| Rob Bresnahan | House | Buy | $1,001 - $15,000 | Feb 25, 2025 |